Evidence map›Paper›PMID 31035722›Full record

ReviewInternational journal of molecular sciences2019

Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome.

Matilde Amatruda, Giulio Ippolito, Sara Vizzuso, Giulia Vizzari, Giuseppe Banderali, Elvira Verduci

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. MiR-130a-3p Has Protective Effects in Alzheimer's Disease via Targeting DAPK1.American journal of Alzheimer's disease and other dementias
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matilde AmatrudaDepartment of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy. Matilde.amatruda@unimi.it.
Giulio IppolitoDepartment of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy. Giulio.ippolito@unimi.it.
Sara VizzusoDepartment of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy. Sara.vizzuso@unimi.it.
Giulia VizzariDepartment of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy. Giulia.Vizzari@unimi.it.
Giuseppe BanderaliDepartment of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy. Giuseppe.banderali@unimi.it.
Elvira VerduciDepartment of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy. Elvira.verduci@unimi.it.
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood obesity represents an important public health issue worldwide and is strongly linked to metabolic alterations such as hypertension, insulin resistance, and dyslipidemia. The constellation of these conditions is commonly known as Metabolic Syndrome (MetS). Metabolic syndrome is not just a simple cluster of metabolic complications due to excess of adipose tissue, but is considered a risk factor for cardiovascular diseases. Evidence from several human and animal studies suggests that environmental and nutritional exposure during pregnancy may affect the newborn development and future health through epigenetic changes, playing a potential role in determining obesity and obesity-related complications. Understanding how nutritional epigenetic mechanisms contribute to the "transgenerational risk" for obesity and metabolic dysfunction is crucial in order to develop early prevention strategies for children's health. Nutrigenetics is the science that studies the role of nutrients in gene expression. Long Chain Polyunsaturated Fatty Acids (LCPUFAs) are known for their health benefits, especially in relation to their ability to modulate inflammation and improve some obesity-associated comorbidities, mainly by decreasing plasma triglycerides. Recent nutrigenetic research is focusing on the potential role of LCPUFAs in influencing epigenetic markers. In this review, we present the most recent updates about the possible interaction between n-3 LCPUFAs and epigenetic pathways in metabolic syndrome. Literature from MEDLINE

Indexed as

Epigenesis, GeneticAcetylationAge FactorsAnimalsBiomarkersDisease SusceptibilityEndoplasmic ReticulumFatty Acids, Omega-3HistonesHumansMetabolic Networks and PathwaysMetabolic SyndromePeroxisomesSite-Specific DNA-Methyltransferase (Adenine-Specific)BiomarkersDNA modification methylase CcrMFatty Acids, Omega-3HistonesSite-Specific DNA-Methyltransferase (Adenine-Specific)DHAepigeneticsLCPUFAsmetabolic syndromenutritional programmingpediatric obesity

Identifiers

PMID31035722
PMCPMC6539774
OpenAlexW2943659776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.